Está en... Inicio >
Medicina >
Farmacología >
Pharmacogenomics of Human Drug Transporters - Ishikawa / B. Kim / Konig
Pharmacogenomics of Human Drug Transporters - Ishikawa / B. Kim / Konig
Descripción
Author : Ishikawa / B. Kim / Konig Language: English Finishing : Hardcover, 440 pages ISBN : 978-0-470-92794-6 Edition Number: 2013 Author Information: TOSHIHISA ISHIKAWA, PhD, is Senior Scientist at RIKEN Yokohama Institute and Professor of Biochemistry, Molecular Biology, and Pharmacogenomics at Yokohama City University's Graduate School of Medicine. Previously, Dr. Ishikawa was the Director of the...
Ver descripción completa
Descripción completa de: Pharmacogenomics of Human Drug Transporters - Ishikawa / B. Kim / Konig
Author : Ishikawa / B. Kim / Konig
Language: English
Finishing : Hardcover, 440 pages
ISBN : 978-0-470-92794-6
Edition Number: 2013
Author Information:
TOSHIHISA ISHIKAWA, PhD, is Senior Scientist at RIKEN Yokohama Institute and Professor of Biochemistry, Molecular Biology, and Pharmacogenomics at Yokohama City University's Graduate School of Medicine. Previously, Dr. Ishikawa was the Director of the Department of Research Technology Development at Pfizer, Japan. A recipient of the Achievement Award from the International Life Sciences Institute (ILSI), Dr. Ishikawa is also the cofounder of the International Transporter Consortium (ITC).
RICHARD B. KIM, MD, FRCPC, is Professor and Chair of the Division of Clinical Pharmacology and Associate Chair for Research in the Department of Medicine at the University of Western Ontario. He is a Fellow of the American Association of Pharmaceutical Scientists and an elected member of the American Society for Clinical Investigation.
JÖRG KÖNIG, PhD, is Professor and Head of the Molecular Biology Laboratories in the Department of Clinical Pharmacology at the Friedrich-Alexander Universität Erlangen-Nürnberg.
Description:
Sets the foundation for safer, more effective drug therapies
With this book as their guide, readers will discover how to apply our current understanding of the pharmacogenomics of drug transporters to advance their own drug discovery and development efforts. In particular, the book explains how new findings in the field now enable researchers to more accurately predict drug interactions and adverse drug reactions. Moreover, it sets the foundation for the development of drug therapies that are tailored to an individual patient's genetics.
Pharmacogenomics of Human Drug Transporters serves as a comprehensive guide to how transporters regulate the absorption, distribution, and elimination of drugs in the body as well as how an individual's genome affects those processes. The book's eighteen chapters have been authored by a team of leading pioneers in the field. Based on their own laboratory and clinical experience as well as a thorough review of the literature, these authors explore all facets of drug transporter pharmacogenomics, including:
- Individual drug transporters and transporter families and their clinical significance
- Principles of altered drug transport in drug–drug interactions, pharmacotherapy, and personalized medicine
- Emerging new technologies for rapid detection of genetic polymorphisms
- Clinical aspects of genetic polymorphisms in major drug transporter genes
- Future research directions of drug transporter pharmacogenomics and the prospect of individualized medicine
Pharmacogenomics of Human Drug Transporters opens the door to new drug discovery and development breakthroughs leading to safer and more effective customized drug therapies.The book is recommended for pharmaceutical scientists, biochemists, pharmacologists, clinicians, and genetics and genomics researchers.
Table Of Contents:
- PREFACE vii
- CONTRIBUTORS ix
- CHAPTER 1 INTRODUCTION TO PHARMACOGENOMICS OF DRUG TRANSPORTERS 1
- Marianne K. DeGorter and Richard B. Kim
- CHAPTER 2 ADME PHARMACOGENOMICS IN DRUG DEVELOPMENT 13
- Liangfu Chen and Joseph W. Polli
- CHAPTER 3 REGULATORY PERSPECTIVE ON PHARMACOGENOMICS OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS 39
- Lei Zhang, Gilbert J. Burckart, Lawrence J. Lesko and Shiew-Mei Huang
- CHAPTER 4 THE PHARMACOGENOMICS OF MEMBRANE TRANSPORTERS PROJECT 73
- Sook Wah Yee, Deanna L. Kroetz and Kathleen M. Giacomini
- CHAPTER 5 EMERGING NEW TECHNOLOGY OF SNP TYPING 109
- Toshihisa Ishikawa and Yoshihide Hayashizaki
- CHAPTER 6 OATP1A2, OAT1, AND OAT3 125
- Rommel G. Tirona
- CHAPTER 7 OATP1B1, OATP1B3, AND OATP2B1 141
- J¨org K¨onig and Martin F. Fromm
- CHAPTER 8 OCT (SLC22A) AND OCTN FAMILY 171
- Sophie L. Stocker, Arian Emami Riedmaier, Matthias Schwab and Kathleen M. Giacomini
- CHAPTER 9 MATE (SLC47) FAMILY 209
- Atsushi Yonezawa and Ken-ichi Inui
- CHAPTER 10 PEPT (SLC15A) FAMILY 223
- Tomoko Sugiura, Saki Umeda, Akira Tsuji and Yukio Kato
- CHAPTER 11 NUCLEOSIDE TRANSPORTERS (SLC28 AND SLC29) FAMILY 243
- M´ýriam Molina-Arcas and Marc¸al Pastor-Anglada
- CHAPTER 12 P-GLYCOPROTEIN (MDR1/ABCB1) 271
- Ingolf Cascorbi
- CHAPTER 13 BSEP (ABCB11) 295
- Bruno Stieger and Gerd A. Kullak-Ublick
- CHAPTER 14 BCRP (ABCG2) 311
- Agnes Basseville, Susan E. Bates, William D. Figg and Alex Sparreboom
- CHAPTER 15 MRP2 (ABCC2) AND MRP3 (ABCC3) 345
- Anne T. Nies
- CHAPTER 16 MRP4 (ABCC4) 365
- Satish B. Cheepala, Mugdha Sukthankar and John D. Schuetz
- CHAPTER 17 MRP8 (ABCC11) 387
- Yu Toyoda and Toshihisa Ishikawa
- CHAPTER 18 FUTURE PERSPECTIVES 401
- Toshihisa Ishikawa and Joseph Ware
- INDEX 417
Puedes encontrar este libro tambien en las siguientes categorías
Valoración: